Volume 11, Number 4—April 2005
Research
Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland
Table 1
Year |
Males | Females | Total | Incidence per 105/y (all cases) | 95% CI* | Patient, <5 y of age | Incidence per 105/y (patients <5 y) | 95% CI* | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||||||||
England | 83 | 66 | 65 | 73 | 139 | 148 | 287 | 0.71 | 0.56–0.89 | 185 | 1.54 | 1.12–2.0 |
Scotland | 12 | 19 | 20 | 12 | 28 | 35 | 63 | 1.56 | 0.9–2.43 | 41 | 3.4 | 1.84–6.17 |
Wales | 3 | 5 | 4 | 5 | 5 | 12 | 17 | 0.71 | 0.27–1.70 | 10 | 1.49 | 0.36–4.18 |
Northern Ireland | 2 | 6 | 4 | 4 | 9 | 7 | 16 | 0.97 | 0.27–1.70 | 7 | 1.45 | 0.2–4.6 |
Ireland | 3 | 7 | 10 | 10 | 14 | 16 | 30 | 0.83 | 0.38–1.6 | 24 | 2.33 | 0.85–5.1 |
Total | 103 | 103 | 103 | 104 | 195 | 218 | 413 | 0.71 | 0.56–0.89 | 267 | 1.54 | 1.12–2.0 |
*CI, confidence interval.
Page created: May 23, 2011
Page updated: May 23, 2011
Page reviewed: May 23, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.